Researchers sought to determine whether expansion of NK cells with IL-15 and nicotinamide would improve responses in patients with NHL and MM.
Researchers sought to determine whether pembrolizumab would induce long-term responses in heavily pretreated patients with relapsed or refractory PMBCL.
Young patients with lymphoma or rhabdomyosarcoma may experience changes in body composition during chemotherapy, research suggests.
Treating advanced melanoma with immune checkpoint inhibitors can be safe and effective in patients with concomitant CLL, a study suggests.
Researchers sought to determine whether orelabrutinib would be effective in patients with relapsed/refractory MZL.